We are live on ! Find out more
CODX

Co-Diagnostics
CODX

14 hedge funds and large institutions have $91.5K invested in Co-Diagnostics in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

2.05% more ownership

Funds ownership: 0.3% → 2.35% (+2%)

53% less funds holding

Funds holding: 30 → 14 (-16)

78% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 18

90% less capital invested

Capital invested by funds: $940K → $91.5K (-$849K)

Holders
14
Holders Change
-16
Holders Change %
-53.33%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
3
Closed
18
Calls
$33K
Puts
–
Net Calls
+$33K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$21.6K
2
PAG
Private Advisory Group
Washington
+$6.83K
3
JP Morgan Chase
JP Morgan Chase
New York
+$96
4
Morgan Stanley
Morgan Stanley
New York
+$51
5
SS
SBI Securities
Japan
+$38

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$123K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$81.2K
3
BlackRock
BlackRock
New York
-$72.1K
4
Jane Street
Jane Street
New York
-$40.6K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$23.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
PAG
1
Private Advisory Group
Washington
$77K +$6.83K +1,999 +5%
UBS Group
2
UBS Group
Switzerland
$13.7K +$21.6K +6,320 +603%
SAM
3
Smartleaf Asset Management
Massachusetts
$226 – – –
Morgan Stanley
4
Morgan Stanley
New York
$164 +$51 +15 +21%
Wells Fargo
5
Wells Fargo
California
$151 -$3 -1 -1%
SS
6
SBI Securities
Japan
$108 +$38 +11 +23%
JP Morgan Chase
7
JP Morgan Chase
New York
$85 +$96 +28 +127%
HWA
8
Heritage Wealth Advisors
Virginia
$32 -$3 -1 -6%
Osaic Holdings
9
Osaic Holdings
Arizona
$18 – – –
DB
10
Danske Bank
Denmark
$13 +$24 +7 New
NA
11
NewEdge Advisors
Louisiana
$11 -$3 -1 -14%
HI
12
Harbour Investments
Wisconsin
$4 +$7 +2 New
Citigroup
13
Citigroup
New York
$2 +$3 +1 New
VFT
14
Vanguard Fiduciary Trust
Pennsylvania
$2 +$3 +1 New
Renaissance Technologies
15
Renaissance Technologies
New York
– -$123K -24,344 Closed
Geode Capital Management
16
Geode Capital Management
Massachusetts
– -$81.2K -14,972 Closed
BlackRock
17
BlackRock
New York
– -$72.1K -14,248 Closed
Jane Street
18
Jane Street
New York
– -$40.6K -8,031 Closed
Bank of New York Mellon
19
Bank of New York Mellon
New York
– -$23.1K -4,569 Closed
State Street
20
State Street
Massachusetts
– -$17K -3,355 Closed
KAS
21
Kestra Advisory Services
Texas
– -$14.9K -2,940 Closed
Northern Trust
22
Northern Trust
Illinois
– -$9.27K -1,833 Closed
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
– -$8.3K -1,642 Closed
SFWA
24
Summit Financial Wealth Advisors
Louisiana
– -$6.74K -1,333 Closed
TSS
25
Two Sigma Securities
New York
– -$5.19K -1,026 Closed
1
2

CODX Hedge Fund Activity: Q1 2026 in Review

14 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q1 2026, worth a combined $91.5K — down 90% from $940K a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of CODX and 4 opened new positions — a net loss of 14 holders — while 3 trimmed existing stakes and 5 added.

The largest buyer was UBS Group, adding an estimated $21.6K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $123K sold.

  • 14 institutional investors held Co-Diagnostics (CODX) as of Q1 2026, down from 30 in Q4 2025.
  • Funds reported $91.5K of Co-Diagnostics stock for Q1 2026, down 90% quarter-over-quarter.
  • 4 funds opened new Co-Diagnostics positions in Q1 2026 and 18 closed out, a net change of -14 holders.
  • The largest Co-Diagnostics buyer in Q1 2026 was UBS Group, an estimated $21.6K added.
  • The largest Co-Diagnostics seller in Q1 2026 was Renaissance Technologies, an estimated $123K sold.

Based on aggregated 13F filings for Q1 2026.